CS
TRAW icon

Credit Suisse’s Traws Pharma TRAW Stock Holding History

Credit Suisse’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Hold
0
– -$61K – 4679
2014
Q2 		– Sell
-2
Closed -$590K – 4585
2014
Q1 		$604K Buy
+2
New +$1.2M ﹤0.01% 3562
2013
Q4 		– Hold
0
– – – 4371

Other funds holding TRAW

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Credit Suisse's TRAW Position: Q3 2014 in Review

Credit Suisse held its Traws Pharma (TRAW) position steady in Q3 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4679.

Credit Suisse first reported a position in TRAW in Q1 2014 and has held it in 1 quarter since. The position peaked at $604K in Q1 2014. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2014.

  • Credit Suisse held 0 shares of Traws Pharma worth $0 as of Q3 2014.
  • Credit Suisse left its Traws Pharma share count unchanged in Q3 2014.
  • Traws Pharma made up ﹤0.01% of Credit Suisse's portfolio in Q3 2014, its #4679 holding.
  • Credit Suisse first reported a position in Traws Pharma in Q1 2014 and has held it in 1 quarter since.
  • Credit Suisse's Traws Pharma position peaked at $604K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2014.

Based on Credit Suisse's 13F filing for Q3 2014, filed 14 Nov 2014.